Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
11.30
+0.26 (2.36%)
At close: Sep 28, 2026, 4:00 PM EDT
11.41
+0.11 (0.97%)
Pre-market: Sep 29, 2026, 8:09 AM EDT

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $39.66M in the quarter ending June 30, 2026, with 53.25% growth. This brings the company's revenue in the last twelve months to $136.07M, up 119.40% year-over-year. In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth.

Revenue (ttm)
$136.07M
Revenue Growth
+119.40%
P/S Ratio
4.93
Revenue / Employee
$2,230,672
Employees
61
Market Cap
671.04M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025106.47M82.86M350.91%
Dec 31, 202423.61M-3.85M-14.02%
Dec 31, 202327.46M17.00M162.58%
Dec 31, 202210.46M-18.19M-63.50%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MiMedx Group355.17M
Ginkgo Bioworks Holdings132.42M
Verastem87.53M
OmniAb38.46M
DBV Technologies5.04M
Shattuck Labs1.00M
Silence Therapeutics615.00K
Revenue Rankings

ZVRA News

More News